228 related articles for article (PubMed ID: 18605517)
1. Pharmacologic management of multiple sclerosis.
Blasier MG
Urol Nurs; 2008 Jun; 28(3):217-9. PubMed ID: 18605517
[No Abstract] [Full Text] [Related]
2. [Pharmacological treatment of multiple sclerosis].
Myhr KM
Tidsskr Nor Laegeforen; 2010 Mar; 130(5):490-2. PubMed ID: 20224616
[TBL] [Abstract][Full Text] [Related]
3. A practical approach to immunomodulatory therapy for multiple sclerosis.
Burks JS
Phys Med Rehabil Clin N Am; 2005 May; 16(2):449-66, ix. PubMed ID: 15893681
[TBL] [Abstract][Full Text] [Related]
4. The therapy of multiple sclerosis with immune-modulating or immunosuppressive drug. A critical evaluation based upon evidence based parameters and published systematic reviews.
Clerico M; Rivoiro C; Contessa G; Viglietti D; Durelli L
Clin Neurol Neurosurg; 2008 Nov; 110(9):878-85. PubMed ID: 18164542
[TBL] [Abstract][Full Text] [Related]
5. 'Time is brain' also in multiple sclerosis.
Freedman MS
Mult Scler; 2009 Oct; 15(10):1133-4. PubMed ID: 19808740
[No Abstract] [Full Text] [Related]
6. [Early immunotherapy in MS reduces the risk of later disability. The secondary progressive course is delayed, according to a study with virtual placebo].
Tedeholm H; Skoog B; Hillert J; Runmarker B; Stawiarz L; Oluf A
Lakartidningen; 2007 May 30-Jun 3; 104(22):1684-8. PubMed ID: 17601317
[No Abstract] [Full Text] [Related]
7. Current disease-modifying therapies in multiple sclerosis.
Kieseier BC; Hartung HP
Semin Neurol; 2003 Jun; 23(2):133-46. PubMed ID: 12894379
[TBL] [Abstract][Full Text] [Related]
8. Glatiramer and suspected multiple sclerosis. No proven advantage.
Prescrire Int; 2010 Aug; 19(108):160. PubMed ID: 20941852
[No Abstract] [Full Text] [Related]
9. Multiple sclerosis: interferon beta for some serious forms.
Prescrire Int; 2007 Dec; 16(92):252-7. PubMed ID: 18092425
[TBL] [Abstract][Full Text] [Related]
10. [Advances in the treatment of multiple sclerosis?].
Tackenberg B; Himmerich H; Wellek A; Oertel WH; Sommer N
MMW Fortschr Med; 2007 May; 149 Suppl 2():51-5. PubMed ID: 17724968
[TBL] [Abstract][Full Text] [Related]
11. Disease-modifying drugs for the early treatment of multiple sclerosis.
Flachenecker P
Expert Rev Neurother; 2004 May; 4(3):455-63. PubMed ID: 15853542
[TBL] [Abstract][Full Text] [Related]
12. Confounders in natural history of interferon-beta-treated relapsing multiple sclerosis.
Gout O
Ann Neurol; 2008 Jan; 63(1):126; author reply 126-7. PubMed ID: 17702028
[No Abstract] [Full Text] [Related]
13. Multiple sclerosis. Part 2: ophthalmic issues in MS therapy.
Pula JH; Javed A
Curr Opin Ophthalmol; 2009 Nov; 20(6):476-81. PubMed ID: 19816177
[TBL] [Abstract][Full Text] [Related]
14. Coming of age: the use of immunomodulatory therapy in children with multiple sclerosis.
Banwell B; Tremlett H
Neurology; 2005 Mar; 64(5):778-9. PubMed ID: 15753408
[No Abstract] [Full Text] [Related]
15. Use of interferon-beta in the treatment of multiple sclerosis.
Derwenskus J; Lublin FD
Adv Neurol; 2006; 98():257-71. PubMed ID: 16400838
[No Abstract] [Full Text] [Related]
16. [New approaches in research of therapy of multiple sclerosis].
Hemmer B; Cepok S; Nessler S; Sommer N
Med Klin (Munich); 2001 Sep; 96 Suppl 1():23-8. PubMed ID: 11603112
[TBL] [Abstract][Full Text] [Related]
17. A practical guide to pediatric multiple sclerosis.
Huppke P; Gärtner J
Neuropediatrics; 2010 Aug; 41(4):157-62. PubMed ID: 21086219
[TBL] [Abstract][Full Text] [Related]
18. Use of diagnostic tests and procedures for disease-modifying therapy users and non-disease-modifying therapy users with multiple sclerosis.
Nair KV; Corboy J; Kahler K; Allen RR; Ghushcyan V; McQueen RB; Bainbridge J; Dastani H; Mody-Patel N
Expert Rev Neurother; 2011 Jun; 11(6):787-98. PubMed ID: 21651327
[TBL] [Abstract][Full Text] [Related]
19. The use of interferon Beta and glatiramer acetate in multiple sclerosis.
Goodin DS
Semin Neurol; 2013 Feb; 33(1):13-25. PubMed ID: 23709209
[TBL] [Abstract][Full Text] [Related]
20. [Update: treatment of multiple sclerosis].
Kümpfel T; Hohlfeld R
MMW Fortschr Med; 2009 Mar; 151(13):70-2. PubMed ID: 19504824
[No Abstract] [Full Text] [Related]
[Next] [New Search]
